HopeStage
Back to all studies
UnknownNCT06494124

Efficacy and Safety of tACS vs tDCS in Schizophrenia

Device studyAges 18–60India
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 60 years.

Listed locations
BhubaneswarSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 3, 2024
Recruitment status
Unknown
Enrollment listed in the registry
90
Sponsor
All India Institute of Medical Sciences, Bhubaneswar
Sponsor type
Research institute
Study type
Device
Intervention type
Device
Locations
India
Age range
From 18 Years to 60 Years
Official registry ID
NCT06494124
Official title
Show the full official title

Comparison of Efficacy and Safety of Transcranial Alternating Current Stimulation vs Transcranial Direct Current Stimulation on Psychopathology Measures and Neurocognition in Chronic Schizophrenia: A Randomized Double-blind Controlled Trial

Recruitment & locations

Status unknown

Bhubaneswar

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is All India Institute of Medical Sciences, Bhubaneswar, a research institute.

Who can participate?

Listed age limits: 18 years to 60 years.

Want to explore more studies?

Explore studies